{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11215331", "DateCompleted": {"Year": "2001", "Month": "03", "Day": "22"}, "DateRevised": {"Year": "2017", "Month": "11", "Day": "16"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0004-4172", "JournalIssue": {"Volume": "51", "Issue": "1", "PubDate": {"Year": "2001", "Month": "Jan"}}, "Title": "Arzneimittel-Forschung", "ISOAbbreviation": "Arzneimittelforschung"}, "ArticleTitle": "Immunopharmacological in vitro effects of Eleutherococcus senticosus extracts.", "Pagination": {"StartPage": "76", "EndPage": "83", "MedlinePgn": "76-83"}, "Abstract": {"AbstractText": ["The objective of these investigations was to further elucidate the immunopharmacological profile of fluid extracts of Eleutherococcus senticosus and to identify the specific role of its characteristic eleutherosides B and E. An ethanolic dry extract of Eleutherococcus senticosus was used as starting material for the isolation of the eleutherosides B and E. Immunopharmacological studies included expression of major histocompatibility complex class I and II molecules by rat bone marrow-derived mononuclear phagocytes, human lymphocyte marker flow cytometry, and in vitro testing of human lymphocyte functions. In contrast to the isolated eleutherosides B and eleutherosides E and the re-mixed eleutherosides B and E, the whole ethanolic fluid extract of Eleutherococcus senticosus was able to induce and enhance interleukin-1 and interleukin-6 but not interleukin-2 production in vitro. The effective concentration of the whole ethanolic extract ranged from 1.0-0.1 mg/ml for the enhancement of interleuking-1 alpha production and 1.0-0.03 mg/ml for the enhancement of interleukin-6 production. It is concluded that the observed enhancing immunopharmacological activities on acute phase response mediators are best exhibited by the induction with whole ethanolic extracts whereas the species-specific and characteristic eleutherosides B and E are not associated with these activities."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Boehringer Ingelheim, Biberach/Riss, Germany. gerhard.steinmann@bc.boehringer-ingelheim.com"}], "Identifier": [], "LastName": "Steinmann", "ForeName": "G G", "Initials": "GG"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Esperester", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Joller", "ForeName": "P", "Initials": "P"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Arzneimittelforschung", "NlmUniqueID": "0372660", "ISSNLinking": "0004-4172"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adjuvants, Immunologic"}, {"RegistryNumber": "0", "NameOfSubstance": "CD3 Complex"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucosides"}, {"RegistryNumber": "0", "NameOfSubstance": "HLA-DR Antigens"}, {"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenylpropionates"}, {"RegistryNumber": "0", "NameOfSubstance": "beta 2-Microglobulin"}, {"RegistryNumber": "670-65-5", "NameOfSubstance": "Neopterin"}, {"RegistryNumber": "8JP2P44H3Z", "NameOfSubstance": "eleutheroside E"}, {"RegistryNumber": "I6F5B11C96", "NameOfSubstance": "syringin"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Adjuvants, Immunologic"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Bone Marrow Cells"}, {"QualifierName": ["metabolism"], "DescriptorName": "CD3 Complex"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "CD4-Positive T-Lymphocytes"}, {"QualifierName": ["cytology", "drug effects"], "DescriptorName": "CD8-Positive T-Lymphocytes"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Cytokines"}, {"QualifierName": [], "DescriptorName": "Genes, MHC Class I"}, {"QualifierName": [], "DescriptorName": "Genes, MHC Class II"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Glucosides"}, {"QualifierName": ["metabolism"], "DescriptorName": "HLA-DR Antigens"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Lignans"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Monocytes"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Neopterin"}, {"QualifierName": [], "DescriptorName": "Phenylpropionates"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Spectrophotometry, Infrared"}, {"QualifierName": [], "DescriptorName": "Spectrophotometry, Ultraviolet"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "beta 2-Microglobulin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "2", "Day": "24", "Hour": "12", "Minute": "0"}, {"Year": "2001", "Month": "3", "Day": "27", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "2", "Day": "24", "Hour": "12", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11215331", "10.1055/s-0031-1300006"]}}], "PubmedBookArticle": []}